CLB Forum at ENDO 09: The Premier Event of the Corporate Liaison Board

The Corporate Liaison Board will host the 10^th Annual CLB Forum at ENDO 09. The CLB Forum highlights the collaboration between industry, academia, and government in approaches to treatment of endocrine disorders. All ENDO attendees are welcome, so spread the word to all of your colleagues attending ENDO.

"Biomarkers in Cardiovascular Endocrinology in Clinical Trials & Drug Development"
Wednesday, June 10, 2009
6:30-9:30pm
Renaissance Washington DC Hotel
999 Ninth Street NW

• Program Director: Sethu Reddy, MD
  Merck & Co., Inc.
  
• David A. Fryburg, MD
  Pfizer, Inc.
  "The Mandate for Development of Biomarkers of Atherosclerotic Cardiovascular Disease: Future Implications"
  
• Joseph P. McConnell, PhD
  Mayo Clinic
  "CV Biomarkers: PL A2 Experience"
  
• Mary H. Parks, MD
  Federal Drug Administration
  "Regulatory Perspective"

There is no cost to attend this event, but seating reservations are on a first-come, first-served basis. Please contact Nancy Chill at nchill@endo-society.org or 301-941-0203 for more information. We look forward to seeing you in DC!